SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?


To: Mr. Forthright who wrote (2830)7/8/1998 6:51:00 PM
From: FatMatty  Read Replies (2) | Respond to of 5402
 
Who's hyping here? Haven't seen any in a while.

YOU do the evaluation. Everything you need is here. Please enlighten us with your wisdom.

Waiting...for you to fall on your face again.



To: Mr. Forthright who wrote (2830)7/8/1998 6:56:00 PM
From: Bret Emmett  Read Replies (1) | Respond to of 5402
 
VULTURE! Why don't we ever see you on the up days?
Bret



To: Mr. Forthright who wrote (2830)7/8/1998 7:38:00 PM
From: xbrent  Read Replies (3) | Respond to of 5402
 
Developing medical or RX types of stocks have a tremendous upside if the technology has a large market and they can get thru the trials before the cash runs out. (burn rate) If SGNC is all that it could be it could be $100 stock. But we all know that that is a real long shot.
If you read all the recent posts and even take a conservative careful posture SGNC has a great chance at the big time. The market is there, the technology is logical, the CEO is well regarded, they have a plan and they are allied with others who have credibility and where-with-all.
To try to quantify the value of the company at this point is somewhat futile. I guess you could do it in three ranges 1. great 2. good 3. less than good; then you have three numbers. I happen to think of all the various medical related firms that SGNC looks to me that it could be very successful and that is why I own it and will hold it.